In another recent study, α-lactalbumin (α-LA)-engineered breast cancer cell-derived exosomes were loaded with immunogenic cell death (ICD) inducers Hiltonol (a Toll-like receptor agonist) and human neutrophil elastase (ELANE) to form an in situ DC vaccine (HELA-Exos) [70]. This evidence concerns the gene ELANE and breast cancer.